- Dana White Not Optimistic About GSP Return: He Hasn’t Been Hungry For A Long Time
- Surprise! Aldo & McGregor Hurl PED Accusations At One Another
- CABMMA Changes Drew Dober Loss To No Contest
- Henry Cejudo Added To June’s UFC 188 From Mexico, Chico Camus Rumored Opponent
- UFC 189 World Tour Heats Up In Boston: Dana White Forced To Intervene
- Nick Diaz Hires Professionals To Investigate UFC 183 Drug Test
Robert Drysdale Flagged For Elevated Testosterone, NSAC Declines To Clear Him For UFC 167
There are bits of news that no MMA fan ever wants to hear and one of the worst has to do with a fighter failing a drug test. Today, that appears to be the case with Robert Drysdale.
The 32 year old Brazilian Jiu Jitsu master was supposed to have made his UFC debut back in August at UFC 163, but was a scratch for the event due to a staph infection.
Now it appears that elevated Testosterone levels will prevent Drysdale’s “big show” coming out party, and as the result of an out-of-competition drug test, which placed his ratios at a whopping 3 to 1 over the allowable limit; 19.4 to 1, as opposed to 6 to 1.
To say the least, this is a disappointment.
Fans have been looking forward to the BJJ Phenom’s appearance in the light-heavyweight division for some time, now and for him to miss a second scheduled outing as the result of a failed (for the first time) drug test, and for something that the Nevada State Athletic Commission had specifically denied him use of, back in July, when he applied for a testosterone exemption waiver, will be hard for him to to defend to both fans and to the UFC.
It also begs the question as to whether or not his scratch from UFC 163 was due, legitimately, to a staph infection, or whether or not it was (simply) a convenient excuse, because he was fearful of failing a post-fight drug test, for elevated T/E levels. The facts and circumstances are pause for consideration, at least.
This is worth noting, because in Drysdale’s application to NSAC for a testosterone therapeutic use exemption or TUE, he acknowledged that his doctor had been prescribing him weekly injections of the drug for a diagnosis of hypogonadism; a condition by which the body fails to produce normal levels of testosterone.
In synopsis, this will be a blight on Drysdale’s reputation and not something that’s apt to curry favor with UFC President Dana White. To be blunt, fans shouldn’t be surprised if White washes his hands of Drysdale for this failure, and if for no other reason than the suspicion that Drysdale’s UFC 163 scratch was a ruse; that Drysdale didn’t have a staph infection, but rather blatantly lied about having it to avoid a drug test he knew he couldn’t pass.
Either way, UFC 167 will still take place on the 16th of next month in Las Vegas and the UFC will continue on, with or without, the brilliance of Robert Drysdale Jiu Jitsu skills. Again and on this issue, fans will forever wonder why talented fighters, such as Drysdale, search for answers in a needle rather than solutions in the gym. And where Drysdale’s lack of show will have no impact on the main card, it certainly diminishes the preliminary lead-in. In a word, Drysdale’s failure to pass an out-of-competition drug test is lamentable.
However and happily, Drysdale’s failure to pass said tests is evidence that NSAC is doing its job; at least regarding the subject of drug testing.
Confirmation of Drysdale’s NSAC test failure is courtesy of MMAJunkie.com.